Biggest News Aggregation in the World
📰 Dvancing News

Page 5 - Dvancing News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Dvancing. Real-time updates on events, politics, business and more.

Rocket Pharmaceuticals Receives European Medicines Agency (EMA) Priority Medicines (PRIME) Designation for RP-A501 Gene Therapy for Danon Disease

Rocket Pharmaceuticals, Inc. , a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need, today... | May 31, 2023
Kinnari Patel Rocket Pharmaceuticals Inc European Medicines Agency York Heart Association Rocket Pharmaceuticals Priority Medicines

MyJournals.org - Science - 'IJERPH, Vol. 20, Pages 6010: An Agenda for Advancing Research and Prevention at the Nexus of Work Organization, Occupational Stress, and Mental Health and Well-Being' (International Journal of Environmental Research and Public Health)

MyJournals.org - Science - IJERPH, Vol. 20, Pages 6010: An Agenda for Advancing Research and Prevention at the Nexus of Work Organization, Occupational Stress, and Mental Health and Well-Being (International Journal of Environmental Research and Public Health)
Special Issue Well Being

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Agendia, Inc.: Agendia Studies Reveal the Influence of Race on a Tumor's Biology, Reinforcing its Commitment to Advancing Research of Racial Disparities in Breast Cancer

Data presented at the 2023 ASCO® Annual Meeting confirms BluePrint® accurately reveals the driving forces behind a tumor's growth, independent of race With over 1,000 Black women enrolled
United States Kerry Harrington William Audeh Agendia Inc Annual Meeting Chief Medical Officer

PepGen Inc. Announces Clinical Hold in the U.S. on IND Application to Initiate a Phase 1 Study of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1)

BOSTON, May 30, 2023 -- PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe... | May 30, 2023
United States Laurence Watts James Mcarthur Drug Administration Health Canada Gilmartin Group

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science